A new study has revealed that postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures.
一项新的研究显示患有糖尿病的绝经妇女在服用噻唑烷二酮类药物，包括匹格列酮与罗格列酮时，会增加骨折的危险。
For more than 10 years, thiazolidinediones (TZDs) have been prescribed for diabetes therapy in the U. S. on the sole basis of evidence that they improve glycemic control.
在美国，基于噻唑啉二酮类药物能提高人体控制血糖的能力，10多年来该药物一直用于糖尿病的治疗。
Thiazolidinediones (TZDs) are a new class of agents commonly used for the treatment of patients with type 2 diabetes or insulin resistance.
噻唑烷二酮类药物是一类新的治疗2型糖尿病和胰岛素抵抗的药物。
应用推荐